Author:
O'Brien Mary E R,Bayliss E J,Stewart Moira E,Smyth John F,Rodger Alan,Leonard R C F
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference7 articles.
1. Bowman A, Allen SG, White G, Leonard RCF (1989) Analysis of prognostic factors for response and survival in advanced breast cancer patients receiving first line chemotherapy. Br J Cancer 60:456
2. Friedman MA, Marcus FS, Cassidy MJ, Resser KJ, Kohler M, Hendrickson GG, Reynolds R, Johnson D, Kilbridge T, Yu K, Cruicitt M (1983) 5-Fluorouracil+oncovin+Adriamycin+mitomycin C (FOAM): an effective program for breast cancer, even for disease refractory to previous chemotherapy. Cancer 52:193?197
3. Henderson IC, Cancellos GP (1980) Cancer of the breast ? the past decade. N Engl J Med 302:17?30, 78?90
4. Luikart SD, Witman GB, Portlock CS (1984) Adriamycin (doxorubicin), vinblastine and mitomycin C in refractory breast cancer. Cancer 53:1252?1255
5. Mattson W, Von Eyben E, Hallstan F, Bjelkengram G (1982) A phase II study of combined 5-fluorouracil and mitomycin C in advanced breast cancer. Cancer 49:217?220
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献